Anti-CD20 as the B-Cell Targeting Agent in a Combined Therapy to Modulate Anti-Factor VIII Immune Responses in Hemophilia a Inhibitor Mice - Liu, CL; Ye, P; Lin, J (Frontiers Immunol, 2014)
et al.